Case 21-2005: A four-week-old male infant with jaundice and thrombocytopenia

New England Journal of Medicine

Volumn 353, Issue 2, 2005, Pages 189-198

  Andrews, Nancy C ^a,c   Anupindi, Sudha ^b,c   Badizadegan, Kamran ^b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; GENTAMICIN; PHENOBARBITAL; VITAMIN K GROUP; ANTIOXIDANT;

ABDOMINAL DISTENSION; ANATOMY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; HEMOCHROMATOSIS; HOMEOSTASIS; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERBILIRUBINEMIA; INFANT; JAUNDICE; LABORATORY TEST; MALE; MATERNAL DISEASE; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN THERAPY; PHOTOTHERAPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; VAGINAL DELIVERY; BIOPSY; BLOOD ANALYSIS; BLOOD EXAMINATION; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; LIVER; MUTATION; NEWBORN; NEWBORN JAUNDICE; PATHOLOGY;

ANTIOXIDANTS; BIOPSY; BLOOD CHEMICAL ANALYSIS; DIAGNOSIS, DIFFERENTIAL; HEMATOLOGIC TESTS; HEMOCHROMATOSIS; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MUTATION; THROMBOCYTOPENIA;

EID: 22044448887     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc059016     Document Type: Article

References (22)

1. Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis. Gastroenterol Clin North Am 2003;32:877-89.
2. Kelly AL, Lunt PW, Rodrigues F, et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet 2001;38:599-610.
3. Shneider BL, Setchell KD, Whitington PF, Neilson KA, Suchy FJ. Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis. J Pediatr 1994;124:234-8.
4. Siafakas CG, Jonas MM, Perez-Atayde AR. Abnormal bile acid metabolism and neonatal hemochromatosis: a subset with poor prognosis. J Pediatr Gastroenterol Nutr 1997;25:321-6.
5. Schoenlebe J, Buyon JP, Zitelli BJ, Friedman D, Greco MA, Knisely AS. Neonatal hemochromatosis associated with maternal autoantibodies against Ro/SS-A and La/SS-B ribonucleoproteins. Am J Dis Child 1993;147:1072-5.
6. Verloes A, Lombet J, Lambert Y, et al. Tricho-hepato-enteric syndrome: further delineation of a distinct syndrome with neonatal hemochromatosis phenotype, intractable diarrhea, and hair anomalies. Am J Med Genet 1997;68:391-5.
7. Parizhskaya M, Reyes J, Jaffe R. Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Dev Pathol 1999;2:360-6.
8. Kershisnik MM, Knisely AS, Sun CC, Andrews JM, Wittwer CT. Cytomegalovirus infection, fetal liver disease, and neonatal hemochromatosis. Hum Pathol 1992;23:1075-80.
9. Fellman V. The GRACILE syndrome, a neonatal lethal metabolic disorder with iron overload. Blood Cells Mol Dis 2002;29:444-50.
10. Lemonde HA, Custard EJ, Bouquet J, et al. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. Gut 2003;52:1494-9.
11. Morris S, Akima S, Dahlstrom JE, Ellwood D, Kent A, Falk MC. Renal tubular dysgenesis and neonatal hemochromatosis without pulmonary hypoplasia. Pediatr Nephrol 2004;19:341-4.
12. Krahenbuhl S, Kleinle S, Henz S, et al. Microvesicular steatosis, hemosiderosis and rapid development of liver cirrhosis in a patient with Pearson's syndrome. J Hepatol 1999;31:550-5.
13. Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 2004;364:1690-8.
14. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
15. Camaschella C, Roetto A, Cali A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-5.
16. Papanikolaou G, Samuels ME, Ludwig EH, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36:77-82.
17. Roetto A, Papanikolaou G, Politou M, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2002;33:21-2.
18. Rosenthal P. Neonatal hepatitis and congenital infections. In: Suchy FJ, Sokol RJ, Balistreri WF, eds. Liver disease in children. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2001:239-52.
19. Fienberg R. Perinatal idiopathic hemochromatosis: giant cell hepatitis interpreted as an inborn error of metabolism. Am J Clin Pathol 1960;33:480-91.
20. Laurendeau T, Hill JE, Manning GB. Idiopathic neonatal hemochromatosis in siblings: an inborn error of metabolism. Arch Pathol 1961;72:410-23.
21. Sigurdsson L, Reyes J, Kocoshis SA, Hansen TW, Rosh J, Knisely AS. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 1998;26:85-9.
22. Flynn DM, Mohan N, McKiernan P, et al. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed 2003;88:F124-F127.